The pooled results showed that a higher circulating OPG level was associated with a higher all-cause mortality risk in CKD patients (adjusted HR, 1.88; 95% CI, 1.45 - 2.44), with low heterogeneity (I2 = 25.7%, P = 0.233). Here, TNFRSF11B is linked to chronic kidney disease.